Related references
Note: Only part of the references are listed.Robust Replication of Genotype-Phenotype Associations across Multiple Diseases in an Electronic Medical Record
Marylyn D. Ritchie et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2010)
Advancing the Science for Active Surveillance: Rationale and Design for the Observational Medical Outcomes Partnership
Paul E. Stang et al.
ANNALS OF INTERNAL MEDICINE (2010)
The serotonin transporter promoter polymorphism (5-HTTLPR) is associated with type 2 diabetes
Maria Iordanidou et al.
CLINICA CHIMICA ACTA (2010)
Differing effect of statins on insulin sensitivity in non-diabetics: A systematic review and meta-analysis
William L. Baker et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Crucial role of the small GTPase Rac1 in insulin-stimulated translocation of glucose transporter 4 to the mouse skeletal muscle sarcolemma
Shuji Ueda et al.
FASEB JOURNAL (2010)
The Genetic Landscape of a Cell
Michael Costanzo et al.
SCIENCE (2010)
Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients
Kwang Kon Koh et al.
ATHEROSCLEROSIS (2009)
Importance of Rac1 Signaling Pathway Inhibition in the Pleiotropic Effects of HMG-CoA Reductase Inhibitors
Mamunur Rashid et al.
CIRCULATION JOURNAL (2009)
Elevated A1C in Adults Without a History of Diabetes in the US
Elizabeth Selvin et al.
DIABETES CARE (2009)
Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis
Swapnil N. Rajpathak et al.
DIABETES CARE (2009)
Quantitative signal detection using spontaneous ADR reporting
A. Bate et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
Expert Perspective: Reducing Cardiovascular Risk in Metabolic Syndrome and Type 2 Diabetes Mellitus Beyond Low-Density Lipoprotein Cholesterol Lowering
Peter H. Jones
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Effects of pravastatin on obesity, diabetes, and adiponectin in diet-induced obese mice
Kana Araki et al.
OBESITY (2008)
Depression and Anxiety in the United States: Findings From the 2006 Behavioral Risk Factor Surveillance System
Tara W. Strine et al.
PSYCHIATRIC SERVICES (2008)
A statistical methodology for drug-drug interaction surveillance
G. Niklas Noren et al.
STATISTICS IN MEDICINE (2008)
Search for genetic variants of the SYNTAXIN 1A (STX1A) gene:: the -352 A>T variant in the STX1A promoter associates with impaired glucose metabolism in an Italian obese population
S. Romeo et al.
INTERNATIONAL JOURNAL OF OBESITY (2008)
Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease
Seigo Sugiyama et al.
ATHEROSCLEROSIS (2007)
A human phenome-interactome network of protein complexes implicated in genetic disorders
Kasper Lage et al.
NATURE BIOTECHNOLOGY (2007)
Obesity, dyslipidemia, and diabetes with selective serotonin reuptake inhibitors: The Hordaland Health Study
Maria B. Raeder et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Serotonin transporter polymorphisms affect human blood glucose control
M Yamakawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Pravastatin does not affect insulin sensitivity and adipocytokines levels in healthy nondiabetic patients
MH Gannagé-Yared et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2005)
Effects of a statin group drug, pravastatin, on the insulin resistance in patients with metabolic syndrome
F Güçlü et al.
BIOMEDICINE & PHARMACOTHERAPY (2004)
Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults - Findings from the National Health and Nutrition Examination Survey, 1999 to 2000
ES Ford et al.
CIRCULATION (2003)
Regulation of the serotonin transporter by interacting proteins
J Haase et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2001)
Share Paper
